Trials / Completed
CompletedNCT02314936
Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation
Dose-ranging Efficacy of Supplementation With Polydextrose, a Dietary Fibre, on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebo-controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 192 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the effectiveness of Polydextrose, a dietary fiber, at decreasing Colonic Transit Time and the gastrointestinal symptoms of Functional Constipation. One quarter of the subjects will receive 12 g of Polydextrose daily, one quarter will receive 8 g of Polydextrose daily, one quarter will receive 4 g of Polydextrose daily and one quarter will receive a placebo daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Litesse powder containing 12 g polydextrose | 12 g polydextrose |
| DIETARY_SUPPLEMENT | Litesse powder containing 8 g polydextrose | 8 g polydextrose, 4 g maltodextrin |
| DIETARY_SUPPLEMENT | Litesse powder containing 4 g polydextrose | 4 g polydextrose, 8 g maltodextrin |
| DIETARY_SUPPLEMENT | Placebo | 12 g Maltodextrin |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-05-01
- First posted
- 2014-12-11
- Last updated
- 2018-11-09
- Results posted
- 2018-11-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02314936. Inclusion in this directory is not an endorsement.